300 related articles for article (PubMed ID: 16536813)
1. Refinement and reduction of the Impact of Psoriasis Questionnaire: classical test theory vs. Rasch analysis.
Nijsten T; Unaeze J; Stern RS
Br J Dermatol; 2006 Apr; 154(4):692-700. PubMed ID: 16536813
[TBL] [Abstract][Full Text] [Related]
2. The reduced Impact of Psoriasis Questionnaire has good psychometric properties in Italian patients.
Nijsten T; Sampogna F; Stern RS; Abeni D
Dermatology; 2007; 215(4):348-51. PubMed ID: 17911994
[TBL] [Abstract][Full Text] [Related]
3. Measuring quality of life of patients with different clinical types of psoriasis using the SF-36.
Sampogna F; Tabolli S; Söderfeldt B; Axtelius B; Aparo U; Abeni D;
Br J Dermatol; 2006 May; 154(5):844-9. PubMed ID: 16634884
[TBL] [Abstract][Full Text] [Related]
4. Maugeri Respiratory Failure questionnaire reduced form: a method for improving the questionnaire using the Rasch model.
Vidotto G; Carone M; Jones PW; Salini S; Bertolotti G;
Disabil Rehabil; 2007 Jul; 29(13):991-8. PubMed ID: 17612984
[TBL] [Abstract][Full Text] [Related]
5. The Family Dermatology Life Quality Index: measuring the secondary impact of skin disease.
Basra MK; Sue-Ho R; Finlay AY
Br J Dermatol; 2007 Mar; 156(3):528-38. PubMed ID: 17300244
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Vision Impairment Questionnaire: an evaluation of its measurement properties using Rasch analysis.
Lamoureux EL; Pallant JF; Pesudovs K; Hassell JB; Keeffe JE
Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4732-41. PubMed ID: 17065481
[TBL] [Abstract][Full Text] [Related]
7. Classical Test Theory versus Rasch analysis for quality of life questionnaire reduction.
Prieto L; Alonso J; Lamarca R
Health Qual Life Outcomes; 2003 Jul; 1():27. PubMed ID: 12952544
[TBL] [Abstract][Full Text] [Related]
8. Rasch analysis of the quality of life and vision function questionnaire.
Gothwal VK; Wright TA; Lamoureux EL; Pesudovs K
Optom Vis Sci; 2009 Jul; 86(7):E836-44. PubMed ID: 19521266
[TBL] [Abstract][Full Text] [Related]
9. The impact of vision impairment questionnaire: an assessment of its domain structure using confirmatory factor analysis and rasch analysis.
Lamoureux EL; Pallant JF; Pesudovs K; Rees G; Hassell JB; Keeffe JE
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1001-6. PubMed ID: 17325138
[TBL] [Abstract][Full Text] [Related]
10. The psoriasis family index: preliminary results of validation of a quality of life instrument for family members of patients with psoriasis.
Eghlileb AM; Basra MK; Finlay AY
Dermatology; 2009; 219(1):63-70. PubMed ID: 19295185
[TBL] [Abstract][Full Text] [Related]
11. Dermatology quality of life scales--a measure of the impact of skin diseases.
Morgan M; McCreedy R; Simpson J; Hay RJ
Br J Dermatol; 1997 Feb; 136(2):202-6. PubMed ID: 9068732
[TBL] [Abstract][Full Text] [Related]
12. Developing a quality of life instrument in patients with psoriasis: the Psoriasis Quality of Life Questionnaire (PQLQ).
Inanir I; Aydemir O; Gündüz K; Danaci AE; Türel A
Int J Dermatol; 2006 Mar; 45(3):234-8. PubMed ID: 16533221
[TBL] [Abstract][Full Text] [Related]
13. Development and preliminary validation of a systemic lupus erythematosus-specific quality-of-life instrument (SLEQOL).
Leong KP; Kong KO; Thong BY; Koh ET; Lian TY; Teh CL; Cheng YK; Chng HH; Badsha H; Law WG; Lau TC; Chew LC; Ho HJ; Pong LY; Hoi LS; Sangeetha N; Chan SP; Howe HS
Rheumatology (Oxford); 2005 Oct; 44(10):1267-76. PubMed ID: 15797980
[TBL] [Abstract][Full Text] [Related]
14. Comparing alternative Rasch-based methods vs raw scores in measuring change in health.
Norquist JM; Fitzpatrick R; Dawson J; Jenkinson C
Med Care; 2004 Jan; 42(1 Suppl):I25-36. PubMed ID: 14707753
[TBL] [Abstract][Full Text] [Related]
15. Are standard instruments valid for the assessment of quality of life and symptoms in glaucoma?
Lamoureux EL; Ferraro JG; Pallant JF; Pesudovs K; Rees G; Keeffe JE
Optom Vis Sci; 2007 Aug; 84(8):789-96. PubMed ID: 17700342
[TBL] [Abstract][Full Text] [Related]
16. Development and evaluation of the quality of life instrument in chronic liver disease patients with minimal hepatic encephalopathy.
Zhou YQ; Chen SY; Jiang LD; Guo CY; Shen ZY; Huang PX; Wang JY
J Gastroenterol Hepatol; 2009 Mar; 24(3):408-15. PubMed ID: 19054261
[TBL] [Abstract][Full Text] [Related]
17. Development of a questionnaire to measure health-related quality of life (HRQoL) in patients with atrial fibrillation (AF-QoL).
Badia X; Arribas F; Ormaetxe JM; Peinado R; de Los Terreros MS
Health Qual Life Outcomes; 2007 Jul; 5():37. PubMed ID: 17610734
[TBL] [Abstract][Full Text] [Related]
18. Psychometric properties of the Dermatology Life Quality Index (DLQI) in 900 Italian patients with psoriasis.
Mazzotti E; Barbaranelli C; Picardi A; Abeni D; Pasquini P
Acta Derm Venereol; 2005; 85(5):409-13. PubMed ID: 16159732
[TBL] [Abstract][Full Text] [Related]
19. A critique of Rasch analysis using the Dyspnoea-12 as an illustrative example.
Yorke J; Horton M; Jones PW
J Adv Nurs; 2012 Jan; 68(1):191-8. PubMed ID: 21658094
[TBL] [Abstract][Full Text] [Related]
20. Catquest-9SF patient outcomes questionnaire: nine-item short-form Rasch-scaled revision of the Catquest questionnaire.
Lundström M; Pesudovs K
J Cataract Refract Surg; 2009 Mar; 35(3):504-13. PubMed ID: 19251145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
